Correlation Between Purple Biotech and CSL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and CSL, you can compare the effects of market volatilities on Purple Biotech and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and CSL.

Diversification Opportunities for Purple Biotech and CSL

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Purple and CSL is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and CSL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL has no effect on the direction of Purple Biotech i.e., Purple Biotech and CSL go up and down completely randomly.

Pair Corralation between Purple Biotech and CSL

Given the investment horizon of 90 days Purple Biotech is expected to under-perform the CSL. In addition to that, Purple Biotech is 6.72 times more volatile than CSL. It trades about -0.05 of its total potential returns per unit of risk. CSL is currently generating about 0.16 per unit of volatility. If you would invest  8,950  in CSL on February 15, 2024 and sell it today you would earn a total of  338.00  from holding CSL or generate 3.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Purple Biotech  vs.  CSL

 Performance 
       Timeline  
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in June 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
CSL 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in CSL are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong essential indicators, CSL is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Purple Biotech and CSL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Purple Biotech and CSL

The main advantage of trading using opposite Purple Biotech and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.
The idea behind Purple Biotech and CSL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges